Cargando…

Feasibility of evaluating the histologic and genetic subtypes of WHO grade II-IV gliomas by diffusion-weighted imaging

BACKGROUND: To explore the feasibility of diffusion-weighted imaging (DWI) metrics to predict the histologic subtypes and genetic status of gliomas (e.g., IDH, MGMT, and TERT) noninvasively. METHODS: One hundred and eleven patients with pathologically confirmed WHO grade II-IV gliomas were recruited...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Sirui, Zhang, Yiwei, Kong, Ziren, Jiang, Chendan, Wang, Yu, Zhao, Dachun, You, Hui, Ma, Wenbin, Feng, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720933/ https://www.ncbi.nlm.nih.gov/pubmed/36471242 http://dx.doi.org/10.1186/s12868-022-00750-8

Ejemplares similares

Thin-Slice Magnetic Resonance Imaging-Based Radiomics Signature Predicts Chromosomal 1p/19q Co-deletion Status in Grade II and III Gliomas
por: Kong, Ziren, et al.
Publicado: (2020)

Gene expression meta-analysis in diffuse low-grade glioma and the corresponding histological subtypes
por: Wang, Siqi, et al.
Publicado: (2017)

Subtyping of gliomas of various WHO grades by the application of immunohistochemistry
por: Popova, Svetlana N, et al.
Publicado: (2014)

(18)F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma
por: Kong, Ziren, et al.
Publicado: (2019)

(18)F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma
por: Kong, Ziren, et al.
Publicado: (2019)

Multiparametric MRI-based differentiation of WHO grade II/III glioma and WHO grade IV glioblastoma
por: Wiestler, Benedikt, et al.
Publicado: (2016)

T2 mapping of molecular subtypes of WHO grade II/III gliomas
por: Kern, Maike, et al.
Publicado: (2020)

DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas
por: Paul, Yashna, et al.
Publicado: (2017)

Feasibility of generalised diffusion kurtosis imaging approach for brain glioma grading
por: Pogosbekian, E. L., et al.
Publicado: (2021)

Microvascular characteristics of lower-grade diffuse gliomas: investigating vessel size imaging for differentiating grades and subtypes
por: Guo, Hong, et al.
Publicado: (2018)

Genomic copy number variation correlates with survival outcomes in WHO grade IV glioma
por: Buchwald, Zachary S., et al.
Publicado: (2020)

WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas
por: Carstam, Louise, et al.
Publicado: (2022)

Larger (18)F-fluoroboronotyrosine (FBY) active volume beyond MRI contrast enhancement in diffuse gliomas than in circumscribed brain tumors
por: Kong, Ziren, et al.
Publicado: (2022)

A Probabilistic Atlas of Diffuse WHO Grade II Glioma Locations in the Brain
por: Parisot, Sarah, et al.
Publicado: (2016)

Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas
por: Kong, Ziren, et al.
Publicado: (2018)

Classification of diffuse lower‐grade glioma based on immunological profiling
por: Wu, Fan, et al.
Publicado: (2020)

CD34 Over-Expression is Associated With Gliomas’ Higher WHO Grade
por: Kong, Xiangyi, et al.
Publicado: (2016)

Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO Classification
por: Gianno, Francesca, et al.
Publicado: (2022)

Classification of Diffuse Glioma Subtype from Clinical-Grade Pathological Images Using Deep Transfer Learning
por: Im, Sanghyuk, et al.
Publicado: (2021)

Racial disparities in histological subtype, stage, tumor grade and cancer-specific survival in lung cancer
por: Zeng, Hui, et al.
Publicado: (2022)

Anatomic mapping of molecular subtypes in diffuse glioma
por: Tang, Qisheng, et al.
Publicado: (2017)

Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma
por: Choi, Jinhyun, et al.
Publicado: (2020)

Identification of molecular subtypes based on inflammatory response in lower-grade glioma
por: Lin, Wanzun, et al.
Publicado: (2022)

The Effect of Histological Subtypes on Outcomes of Stage IV Epithelial Ovarian Cancer
por: Zhou, Juan, et al.
Publicado: (2018)

Diffusion Kurtosis Imaging of Gliomas Grades II and III - A Study of Perilesional Tumor Infiltration, Tumor Grades and Subtypes at Clinical Presentation
por: Delgado, Anna F., et al.
Publicado: (2017)

Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grades III and IV gliomas
por: Bernhardt, Denise, et al.
Publicado: (2020)

Association of perioperative adverse events with subsequent therapy and overall survival in patients with WHO grade III and IV gliomas
por: Weber, Lorenz, et al.
Publicado: (2022)

Molecular Subtypes of Glioblastoma Are Relevant to Lower Grade Glioma
por: Guan, Xiaowei, et al.
Publicado: (2014)

Educational Case: Histologic and Molecular Features of Diffuse Gliomas
por: Zhang, Sarah, et al.
Publicado: (2020)

Facing Contrast-Enhancing Gliomas: Perfusion MRI in Grade III and Grade IV Gliomas according to Tumor Area
por: Di Stefano, Anna Luisa, et al.
Publicado: (2014)

Conventional MRI features can predict the molecular subtype of adult grade 2–3 intracranial diffuse gliomas
por: Lasocki, Arian, et al.
Publicado: (2022)

Risk factors for early progression of diffuse low-grade glioma in adults
por: Wang, Long, et al.
Publicado: (2022)

Clinical Management of Diffuse Low-Grade Gliomas
por: Lombardi, Giuseppe, et al.
Publicado: (2020)

Overexpression of multiple oncogenes related to histological grade of astrocytic glioma.
por: Orian, J. M., et al.
Publicado: (1992)

Perfusion MR Imaging in Gliomas: Comparison with Histologic Tumor Grade
por: Lee, Sun Joo, et al.
Publicado: (2001)

Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis
por: Thust, S. C., et al.
Publicado: (2018)

The Expression of Leptin and Its Receptor During Tumorigenesis of Diffuse Gliomas such as Astrocytoma and Oligodendroglioma- Grade II, III and IV (NOS)
por: Vokuda, Ramya S, et al.
Publicado: (2019)

Combination genetic signature stratifies lower-grade gliomas better than histological grade
por: Chan, Aden Ka-Yin, et al.
Publicado: (2015)

Histological transformation in recurrent WHO grade I meningiomas
por: Corniola, Marco V., et al.
Publicado: (2020)

Transcriptional Characteristics of IDH-Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of IDH-Wild Type WHO Grade IV Gliomas
por: Chang, Yu-Zhou, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o6d2nfq2sscta3680kkvsbjc5s